Postnatal growth restriction alters myocardial mitochondrial energetics in mice

Joseph R Visker1,2, Eric C Leszczynski2, Austin G Wellette-Hunsucker2,3

  • 1The Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah, USA.

Experimental Physiology
|January 5, 2024
PubMed

Insights

Postnatal growth restriction impairs cardiac oxidative phosphorylation, leading to increased reactive oxygen species and potentially raising cardiovascular disease risk. This study investigated the impact of PGR on heart metabolism and mitochondrial function in mice.

Area of Science:

  • Cardiovascular Science
  • Mitochondrial Biology
  • Developmental Biology

Background:

  • Postnatal growth restriction (PGR) is linked to increased cardiovascular disease (CVD) risk.
  • Impaired mitochondrial oxidative phosphorylation (OxPhos) is a potential mechanism connecting PGR and CVD.

Purpose of the Study:

  • To investigate if PGR negatively impacts cardiac metabolism, specifically OxPhos.
  • To assess mitochondrial function, including respiration and reactive oxygen species (ROS) emission, in PGR mice.

Main Methods:

  • FVB mice were exposed to normal-protein (NP) or low-protein (LP) diets before and during gestation.
  • Pups born to NP dams were cross-fostered to LP dams (PGR group) or NP dams (control group).
  • Mitochondrial respirometry and fluorimetry were performed at postnatal days 22 and 80 to measure oxygen consumption and ROS emission.

Main Results:

  • PGR mice exhibited significantly reduced respiratory control in complex I compared to controls.
  • PGR was associated with increased electron leakage and higher reactive oxygen species (ROS) emission.
  • No significant differences in the protein abundance of key mitochondrial proteins were observed between groups.

Conclusions:

  • PGR leads to impaired cardiac mitochondrial function, characterized by reduced respiratory control and elevated ROS production.
  • These mitochondrial deficits in PGR mice may contribute to an increased risk of cardiovascular disease.
  • Further research is warranted to explore therapeutic strategies targeting mitochondrial dysfunction in PGR.

Related Concept Videos